Nihon Medi-Physics Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 6 name spellings.
12
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 18 to 23, 2027 · next Jan 18
- 1 fee due Feb 18, 2027The maintenance fee for Radioactive Fluorine-Labeled Compound (US 9,107,964) comes due Feb 18, 2027. Unpaid by Aug 18, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution (US 11,752,223) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Method for producing [18F]flutemetamol (US 10,472,338) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Jun 15, 2027The maintenance fee for Compound with amyloid affinity (US 9,211,350) comes due Jun 15, 2027. Unpaid by Dec 15, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 24, 2026
- Oct 20 US 12,766,203 Method for Producing Radioactive Zirconium Complex
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,387,266 | Precursor compound of radioactive halogen-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 10,010,632 | Precursor compound of radioactive halogen-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 10,953,112 | Precursor compound of radioactive halogen-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 11,083,804 | Precursor compound of radioactive halogen-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 9,381,259 | Precursor compound of radioactive halogen-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 8,658,132 | Method for production of radiation diagnostic imaging agent In force · USPTO record | In force | USPTO record | |
| US 7,897,811 | Process for production of radioactive fluorine-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 8,790,620 | Radioactive diagnostic imaging agent In force · USPTO record | In force | USPTO record | |
| US 8,269,035 | Process for production of radioactive-fluorine-labeled organic compound In force · USPTO record | In force | USPTO record | |
| US 8,758,724 | Unnatural amino acid radiolabeling precursor In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 31: 1 patent in force now held by others · 40 lapsed for an unpaid fee · 75 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
17 pending · 8 abandoned · 34 no status recorded
Showing 1 to 10 of 59, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/349,201 | Jul 10, 2023 | No status recorded | |
| 18/859,659 | Method for Producing Radioactive Metal Complex | Apr 20, 2023 | Pending |
| 18/842,380 | Method for Producing Complex | Mar 27, 2023 | Pending |
| 18/838,934 | Radioactive Complex of Anti-Vegf Antibody, and Radiopharmaceutical | Feb 14, 2023 | Pending |
| 18/714,548 | Stabilized Radiopharmaceutical Composition | Nov 29, 2022 | Pending |
| 18/688,001 | Radioactive Complex of Deglycosylated Antibody and Radioactive Pharmaceutical Product | Aug 31, 2022 | Pending |
| 18/575,079 | Humanized Antibody That Binds to HEG1 Protein and Complex of Antibody and Radionuclide | Jun 30, 2022 | Pending |
| 17/847,526 | Jun 23, 2022 | No status recorded | |
| 18/556,582 | Humanised Antibodies Labelled with Radionuclides That Emit Beta-Rays | Apr 21, 2022 | Pending |
| 18/556,577 | Radioactive Antitumor Agent | Apr 21, 2022 | Pending |
10 of 59 applications shown.
Pro members see all 59 published applications.